HDM2010
/ Huadong Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 25, 2024
Discovery of HDM2010, a highly potent PTPN2 inhibitor for immunotherapy.
(ASCO 2024)
- "We reported our work on discovering HDM2010, in which a series of potent PTPN2 inhibitors with prominent PK and safety profile were synthesized and characterized. Further optimization including in vivo experiments will lead to a preclinical candidate (PCC) selection."
Gene Therapies • Oncology • IFNG • PTPN2
1 to 1
Of
1
Go to page
1